Dr Nigel Pitchford
United States of America
Nigel joined Imperial Innovations as Managing Director of Healthcare in January 2012, and became Chief Investment Officer of Imperial Innovations Group in October 2013. He was previously a Partner at DFJ Esprit, and prior to that spent 12 years at 3i, becoming a Partner in 2006, and ultimately leading the venture team’s healthcare activities across Europe and the US. He has also served on the boards of EUSA Pharma and HBI. Nigel is currently a non-executive director on the boards of Oxford Immunotec, Polytherics and E3Bio.
Healthcare, Cardiology, Accupuncture, Pulmonary Artery